Novel pebbles in the mosaic of autoimmunity

BMC Medicine

Yehuda Shoenfeld²  Nancy Agmon-Levin³  Carlo Perricone¹ 

[1] Reumatologia, Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Rome, Italy;Incumbent of the Laura Schwarz-Kip Chair for Research of Autoimmune Diseases, Tel-Aviv University, Tel Aviv, Israel;The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer 52621, Israel

关键词: Adjuvant;    Vitamin D;    Systemic lupus erythematosus;    Autoimmune/inflammatory syndrome induced by adjuvants (ASIA);    Autoantibodies;    Autoimmunity;   

Others  :  857100
DOI  :  10.1186/1741-7015-11-101

 received in 2013-03-28, accepted in 2013-04-02,  发布年份 2013

【 摘 要 】

Almost 25 years ago, the concept of the ‘mosaic of autoimmunity’ was introduced to the scientific community, and since then this concept has continuously evolved, with new pebbles being added regularly. We are now looking at an era in which the players of autoimmunity have changed names and roles. In this issue of BMC Medicine, several aspects of autoimmunity have been addressed, suggesting that we are now at the forefront of autoimmunity science. Within the environmental factors generating autoimmunity are now included unsuspected molecules such as vitamin D and aluminum. Some adjuvants such as aluminum are recognized as causal factors in the development of the autoimmune response. An entirely new syndrome, the autoimmune/inflammatory syndrome induced by adjuvants (ASIA), has been recently described. This is the new wind blowing within the branches of autoimmunity, adding knowledge to physicians for helping patients with autoimmune disease.

【 授权许可】

   
2013 Perricone et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Shoenfeld Y, Isenberg DA: The mosaic of autoimmunity. Immunol Today 1989, 10:123-6.
• [2]Amital H, Eric Gershwin M, Shoenfeld Y: Reshaping the mosaic of autoimmunity. Semin Arthritis Rheum 2006, 35:341-3.
• [3]Perricone R, Perricone C, Shoenfeld Y: Autoimmunity: when the immune system becomes the self-ish giant. Autoimmun Rev 2011, 10:575-6.
• [4]Perricone C, Ceccarelli F, Valesini G: An overview on the genetic of rheumatoid arthritis: a never-ending story. Autoimmun Rev 2011, 10:599-608.
• [5]Anaya JM: Common mechanisms of autoimmune diseases (the autoimmune tautology). Autoimmun Rev 2012, 11:781-4.
• [6]Cardenas-Roldan J, Rojas-Villarraga A, Anaya JM: How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med 2013, 11:73. BioMed Central Full Text
• [7]Anaya JM, Rojas-Villarraga A, García-Carrasco M: The autoimmune tautology: from polyautoimmunity and familial autoimmunity to the autoimmune genes. Autoimmune Dis 2012, 2012:297193.
• [8]Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya JM: Autoimmune diseases in the intensive care unit. An update. Autoimmun Rev 2013, 12:380-95.
• [9]Vadasz Z, Haj T, Kessel A, Toubi E: Age-related autoimmunity. BMC Med 2013, 11:94. BioMed Central Full Text
• [10]Chimenti MS, Ballanti E, Perricone C, Cipriani P, Giacomelli R, Perricone R: Immunomodulation in psoriatic arthritis: Focus on cellular and molecular pathways. Autoimmun Rev 2013, 12:599-606.
• [11]Pollard KM, Kono DH: Requirements for innate immune pathways in environmentally induced autoimmunity. BMC Med 2013, 11:100. BioMed Central Full Text
• [12]Toubi E, Shoenfeld Y: Toll-like receptors and their role in the development of autoimmune diseases. Autoimmunity 2004, 37:183-8.
• [13]de Carvalho JF, Pereira RM, Shoenfeld Y: The mosaic of autoimmunity: the role of environmental factors. Front Biosci (Elite Ed) 2009, 1:501-9.
• [14]Torres-Aguilar H, Blank M, Jara LJ, Shoenfeld Y: Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity. Autoimmun Rev 2010, 10:8-17.
• [15]Grossman C, Dovrish Z, Shoenfeld Y, Amital H: Do infections facilitate the emergence of systemic sclerosis? Autoimmun Rev 2011, 10:244-7.
• [16]Ramagopalan SV, Goldacre R, Skingsley A, Conlon C, Goldacre M: Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies. BMC Med 2013, 11:97. BioMed Central Full Text
• [17]Ribeiro FM, Szyper-Kravitz M, Klumb EM, Lannes G, Ribeiro FR, Albuquerque EM, Shoenfeld Y: Can lupus flares be associated with tuberculosis infection? Clin Rev Allergy Immunol 2010, 38:163-8.
• [18]Shapira Y, Agmon-Levin N, Shoenfeld Y: Mycobacterium tuberculosis, autoimmunity, and vitamin D. Clin Rev Allergy Immunol 2010, 38:169-77.
• [19]Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y: Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol 2012., 14
• [20]Perricone C, Agmon-Levin N, Colafrancesco S, Shoenfeld Y: Vitamins and systemic lupus erythematosus: to D or not to D. Exper Rev Clin Immunol 2013., 9
• [21]Disanto G, Chaplin G, Morahan JM, Giovannoni G, Hyppönen E, Ebers GC, Ramagopalan SV: Month of birth, vitamin D and risk of immune mediated disease: a case control study. BMC Med 2012, 10:69. BioMed Central Full Text
• [22]Tincani A, Andreoli L, Cavazzana I, Doria A, Favero M, Fenini MG, Franceschini F, Lojacono A, Nascimbeni G, Santoro A, Semeraro F, Toniati P, Shoenfeld Y: Novel aspects of Sjogren's syndrome in 2012. BMC Med 2013, 11:93. BioMed Central Full Text
• [23]Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y: Sjögren's syndrome, the old and the new. Best Pract Res Clin Rheumatol 2012, 26:105-17.
• [24]Agmon-Levin N, Kivity S, Tzioufas AG, López Hoyos M, Rozman B, Efes I, Shapira Y, Shamis A, Amital H, Youinou P, Shoenfeld Y: Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome. J Autoimmun 2012, 39:234-9.
• [25]McMahon MI, Ackland GJ: Aluminium: Simple metal no more. Nat Mater 2010, 9:607-8.
• [26]Khan Z, Combadière C, Authier FJ, Itier V, Lux F, Exley C, Mahrouf-Yorgov M, Decrouy X, Moretto P, Tillement O, Gherardi RK, Cadusseau J: Slow CCL2-dependent translocation of biopersistent particles from muscle to brain. BMC Med 2013, 11:99. BioMed Central Full Text
• [27]Shoenfeld Y, Agmon-Levin N: 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011, 36:4-8.
• [28]Fierens K, Kool M: The mechanism of adjuvanticity of aluminium-containing formulas. Curr Pharm Des 2012, 18:2305-13.
• [29]Conti F, Alessandri C, Perricone C, Scrivo R, Rezai S, Ceccarelli F, Spinelli FR, Ortona E, Marianetti M, Mina C, Valesini G: Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage. PLoS One 2012, 7:e33824.
• [30]Carmona-Fernandes D, Santos MJ, Canhão H, Fonseca JE: Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile. BMC Med 2013, 11:98. BioMed Central Full Text
• [31]Blank M, Shoenfeld Y: The story of the 16/6 idiotype and systemic lupus erythematosus. Isr Med Assoc J 2008, 10:37-9.
• [32]Perricone C, Shoenfeld N, Agmon-Levin N, de Carolis C, Perricone R, Shoenfeld Y: Smell and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol 2012.
• [33]Kivity S, Katzav A, Arango MT, Landau-Rabi M, Zafrir Y, Agmon-Levin N, Blank M, Anaya JM, Mozes E, Chapman J, Shoenfeld Y: 16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus. BMC Med 2013, 11:90. BioMed Central Full Text
• [34]Blank M, Nur I, Toub O, Maor A, Shoenfeld Y: Toward molecular targeting with specific intravenous immunoglobulin preparation. Clin Rev Allergy Immunol 2005, 29:213-7.
• [35]Gono T, Kawaguchi Y, Yamanaka H: Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy. BMC Medicine 2013, 11:91. BioMed Central Full Text
• [36]Katzav A, Grigoriadis NC, Ebert T, Touloumi O, Blank M, Pick CG, Shoenfeld Y, Chapman J: Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice. BMC Med 2013, 11:91. BioMed Central Full Text
• [37]Lerner A, Agmon-Levine N, Shapira Y, Gilburd B, Reuter S, Lavi I, Shoenfeld Y: The thrombophilic network of autoantibodies in celiac disease. BMC Med 2013, 11:89. BioMed Central Full Text
• [38]Kronbichler A, Mayer G: Renal involvement in autoimmune connective tissue diseases. BMC Med 2013, 11:95. BioMed Central Full Text
• [39]Borchers AT, Leibushor N, Naguwa SM, Cheema GS, Shoenfeld Y, Gershwin ME: Lupus nephritis: a critical review. Autoimmun Rev 2012, 12:174-94.
• [40]Odoardi F, Sie C, Streyl K, Ulaganathan VK, Schläger C, Lodygin D, Heckelsmiller K, Nietfeld W, Ellwart J, Klinkert WE, Lottaz C, Nosov M, Brinkmann V, Spang R, Lehrach H, Vingron M, Wekerle H, Flügel-Koch C, Flügel A: T cells become licensed in the lung to enter the central nervous system. Nature 2012, 488:675-9.
• [41]Steinman L: Weighing in on autoimmune disease: 'Hub-and-spoke' T cell traffic in autoimmunity. Nat Med 2013, 19:139-41.
• [42]Rosman Z, Shoenfeld Y, Zandman-Goddard G: Biologic therapy for autoimmune diseases: an update. BMC Med 2013, 11:88. BioMed Central Full Text